Back to today’s briefing

Story perspectives

FDA Reconsiders Pfizer Vaccine for Young Children Amid Surge

8/13/2025

30 4

Summary

Story summary

The FDA is reconsidering the authorization of Pfizer's Covid-19 vaccine for children under 5, potentially restricting access for the most vulnerable. With hospitalization rates among young children still alarmingly high, the CDC's new guidelines emphasize the need for consultation before vaccination, intensifying worries as Covid-19 cases surge across the US.

1 of 1

Story summary

The FDA is reconsidering the authorization of Pfizer's Covid-19 vaccine for children under 5, potentially restricting access for the most vulnerable. With hospitalization rates among young children still alarmingly high, the CDC's new guidelines emphasize the need for consultation before vaccination, intensifying worries as Covid-19 cases surge across the US.